Development of 125I-methylene blue for sentinel lymph node biopsy

J Surg Oncol. 2006 Sep 15;94(4):293-7. doi: 10.1002/jso.20444.

Abstract

Background: Sentinel lymph node biopsy is an established alternative to complete lymph node dissection in some patients. We have developed a novel, radiolabeled methylene blue dye that may be a useful alternative to the traditional two-step procedure involving 99mTc-labeled colloid and unlabeled blue dye. We hypothesize that 125I-labeled methylene blue will be rapidly absorbed into the lymphatics and transported to the drainage basin containing the sentinel nodes.

Materials and methods: Rabbits footpads were injected with 1 mCi of 125I-labeled methylene blue admixed with unlabeled dye. A hand-held gamma detection device allowed tracking of radiolabeled dye to nodes in the popliteal and inguinal regions. At pre-established time points animals were sacrificed, and the nodal basin dissected. Nodal radioactivity as well as uptake of blue dye was recorded.

Results: The spread of the radiolabeled methylene blue compound from the footpad to the popliteal lymph nodes occurred in 5-10 min.

Conclusion: The radiolabeled dye rapidly progresses through lymphatics to the draining nodes. Use of radiolabeled methylene blue may be an attractive alternative to current two-step sentinel node techniques, as it may be less painful, and may reduce the cost associated with the time-delay between the injection of the radioactive compound and surgery.

MeSH terms

  • Animals
  • Injections
  • Iodine Radioisotopes*
  • Lymph Node Excision
  • Lymph Nodes / diagnostic imaging*
  • Lymph Nodes / pathology
  • Methylene Blue*
  • Rabbits
  • Radionuclide Imaging
  • Sentinel Lymph Node Biopsy / methods*

Substances

  • Iodine Radioisotopes
  • Methylene Blue